Kaito A Nagashima (Kaito Nagashima)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Coronavirus Disease

Top Venues

Communications biology

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Kaito A Nagashima, Nada Abbadi, Ved Vyas, Abigail Roegner, Ted M Ross, Jarrod J Mousa
Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses 15 (2) (2023)
John V Dzimianski, Julianna Han, Giuseppe Andrea Sautto, Sara M O'Rourke, Joseph M Cruz, Spencer R Pierce, Jeffrey W Ecker, Michael A Carlock, Kaito A Nagashima, Jarrod J Mousa, Ted M Ross, Andrew B Ward, Rebecca M DuBois
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications biology 6 (1) (2023)
Kaito A Nagashima, Nada Abbadi, Ved Vyas, Abigail Roegner, Ted M Ross, Jarrod J Mousa
Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses 15 (2) (2023)
John V Dzimianski, Julianna Han, Giuseppe Andrea Sautto, Sara M O'Rourke, Joseph M Cruz, Spencer R Pierce, Jeffrey W Ecker, Michael A Carlock, Kaito A Nagashima, Jarrod J Mousa, Ted M Ross, Andrew B Ward, Rebecca M DuBois
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications biology 6 (1) (2023)
Kaito A Nagashima, John V Dzimianski, Julianna Han, Nada Abbadi, Aaron D Gingerich, Fredejah Royer, Sara M O'Rourke, Giuseppe Andrea Sautto, Ted M Ross, Andrew B Ward, Rebecca M DuBois, Jarrod J Mousa
The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines. Journal of immunology (Baltimore, Md. : 1950) 209 (1) (2022)